Friday, September 18, 2020 1:25:16 PM
Just a thought but with a 290K float, 300 shareholders to go to Nasdaq would only be an average of 1000 shares each at $4/share is $4,000 each. 20, 5% share holders is 14,500 shares each for float lock folks.
Once that happens and they hold, and 99.99999999% of the market hears about NDTP for the first time this could go nuts to $100/share in a week once the SEC filing drops and folks see the UPennMed JV contract and research history and tech is all real, tech that can cross the BBB Blood Brain Barrier and enable self repair of the brain by simply delivering nutrients to the brain, nutrients that the brain is starved for.
It is all documented in 13 years of Michael W Fountain (10% shareholder of the 7 year old private firm that R/M'd to form NDTP, which has been confirmed to have happened per the website at http://www.NDTPharma.com a week ago), and documented in Dr, Cohen UPennMed research papers I nailed down and found.
Took me 400 hours and 500,000 pages of Patents and research papers and SEC history, and people history and DD reading it all to nail down who and where and what on this story is what, and the history of it all.
Being a research grant winner and author myself, and a patent holder and writer I have access to those papers and know how to read and understand them.
Here is the 2010 Univ of So Florida #TBI Traumatic Brain Injury paper, that had every department head at the Univ including Fountain ( a co-author) involved with NIH, National Institute of Health and the Vet Admin (US-DOD-Department of Defense, Vets with Brain Injuries was and is a #1 R&D effort from Middle east wars...) co funding the research. And note the Green Tea Extract EGCG Green Tea Extract in the articles from 2010 to 2020!!!!
https://cdn.discordapp.com/attachments/697524935181992036/697553361792139274/Nanolipidic_particles_improve_the_bioava_1.pdf
Then look at the use of EGCG in Dr. Cohen's paper 3-6 years later and wording in it that is the same word for word as wording in the 2016 SEC filing for the Private firm, CCA,LLC that R/M'd here to form NDTP, the same firm that Michael W Fountain was co-founder of in 2013.
Dr. Cohen, UPennMed 2018 paper on TBI and sleep:
https://cdn.discordapp.com/attachments/754098472441085972/754098967305781389/TBIsleep.pdf
2013 (year CCA, LLC was formed) Dr. Cohen co-authored paper:
https://cdn.discordapp.com/attachments/754098472441085972/756563917257572473/TBIsleep1.pdf
Green Tea extract EGCG is in all of the , Fountain in 2010, Cohen on 2013, and 2018. All roads to $NDTP my NTDP friends
This was almost all non SEC, Public info, that takes an AI effort or hard case like me
to find and figure out LOLOL.
Dementia caused Alzheimer repair is also discused!!!!
"Sleep disorders are highly prevalent in patients with traumatic brain injury (TBI) and can significantly impair cognitive rehabilitation. No proven therapies exist to mitigate the neurocognitive consequences of TBI. We show that mild brain injury in mice causes a persistent inability to maintain wakefulness and decreases orexin neuron activation during wakefulness. We gave mice a dietary supplement of branched-chain amino acids (BCAAs),
precursors for de novo glutamate synthesis in the brain. BCAA therapy reinstated activation of orexin neurons
and improved wake deficits in mice with mild brain injury. Our data suggest that dietary BCAA intervention,
acting in part through orexin, can ameliorate injury-induced sleep disturbances and may facilitate cognitive reha-
bilitation after brain injury."
BCAA Branched Chain Amino Acids and EGCG Green Tea Extract!!
Once that happens and they hold, and 99.99999999% of the market hears about NDTP for the first time this could go nuts to $100/share in a week once the SEC filing drops and folks see the UPennMed JV contract and research history and tech is all real, tech that can cross the BBB Blood Brain Barrier and enable self repair of the brain by simply delivering nutrients to the brain, nutrients that the brain is starved for.
It is all documented in 13 years of Michael W Fountain (10% shareholder of the 7 year old private firm that R/M'd to form NDTP, which has been confirmed to have happened per the website at http://www.NDTPharma.com a week ago), and documented in Dr, Cohen UPennMed research papers I nailed down and found.
Took me 400 hours and 500,000 pages of Patents and research papers and SEC history, and people history and DD reading it all to nail down who and where and what on this story is what, and the history of it all.
Being a research grant winner and author myself, and a patent holder and writer I have access to those papers and know how to read and understand them.
Here is the 2010 Univ of So Florida #TBI Traumatic Brain Injury paper, that had every department head at the Univ including Fountain ( a co-author) involved with NIH, National Institute of Health and the Vet Admin (US-DOD-Department of Defense, Vets with Brain Injuries was and is a #1 R&D effort from Middle east wars...) co funding the research. And note the Green Tea Extract EGCG Green Tea Extract in the articles from 2010 to 2020!!!!
https://cdn.discordapp.com/attachments/697524935181992036/697553361792139274/Nanolipidic_particles_improve_the_bioava_1.pdf
Then look at the use of EGCG in Dr. Cohen's paper 3-6 years later and wording in it that is the same word for word as wording in the 2016 SEC filing for the Private firm, CCA,LLC that R/M'd here to form NDTP, the same firm that Michael W Fountain was co-founder of in 2013.
Dr. Cohen, UPennMed 2018 paper on TBI and sleep:
https://cdn.discordapp.com/attachments/754098472441085972/754098967305781389/TBIsleep.pdf
2013 (year CCA, LLC was formed) Dr. Cohen co-authored paper:
https://cdn.discordapp.com/attachments/754098472441085972/756563917257572473/TBIsleep1.pdf
Green Tea extract EGCG is in all of the , Fountain in 2010, Cohen on 2013, and 2018. All roads to $NDTP my NTDP friends
This was almost all non SEC, Public info, that takes an AI effort or hard case like me
Dementia caused Alzheimer repair is also discused!!!!
"Sleep disorders are highly prevalent in patients with traumatic brain injury (TBI) and can significantly impair cognitive rehabilitation. No proven therapies exist to mitigate the neurocognitive consequences of TBI. We show that mild brain injury in mice causes a persistent inability to maintain wakefulness and decreases orexin neuron activation during wakefulness. We gave mice a dietary supplement of branched-chain amino acids (BCAAs),
precursors for de novo glutamate synthesis in the brain. BCAA therapy reinstated activation of orexin neurons
and improved wake deficits in mice with mild brain injury. Our data suggest that dietary BCAA intervention,
acting in part through orexin, can ameliorate injury-induced sleep disturbances and may facilitate cognitive reha-
bilitation after brain injury."
BCAA Branched Chain Amino Acids and EGCG Green Tea Extract!!
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent NDTP News
- NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant • GlobeNewswire Inc. • 02/05/2026 02:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog • GlobeNewswire Inc. • 01/14/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s wholly owned subsidiary, Good Salt Life, Inc., Advances into AI-Robotics for Unmanned Hospital Disinfection • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant • GlobeNewswire Inc. • 01/08/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals • GlobeNewswire Inc. • 12/19/2025 01:36:01 PM
- Good Salt Life, Inc.'s Induction Charge Delivery Systems Deployed to Protect Show Horses from Widespread EHV-1 Outbreak • ACCESS Newswire • 11/26/2025 01:00:00 PM
- NDT Pharmaceuticals' Subsidiary, Good Salt(TM) Life, Secures Major Government Contract, Deploying Advanced Biosafety Ecosystem in Tennessee State Prisons • ACCESS Newswire • 11/24/2025 02:00:00 PM
- FatPipe, Jackpot Digital, and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 11/07/2025 02:00:00 PM
- 60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 10/31/2025 01:00:00 PM
- Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5 • ACCESS Newswire • 10/30/2025 12:30:00 PM
- NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line • ACCESS Newswire • 10/21/2025 12:30:00 PM
- Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System • ACCESS Newswire • 10/13/2025 12:30:00 PM
- Good Salt Life Expands EPA Registrations and Anticipates New Milestone • ACCESS Newswire • 10/09/2025 12:30:00 PM
- NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets • ACCESS Newswire • 09/23/2025 01:10:00 PM
